Dr. Julie Laliberte, R&D Director at Singleron Biotechnologies presents on CLindex, a new sample multiplexing method developed by Singleron.
Leave no cell behind: How to overcome the limitations of sample multiplexing, to remove species and cell-type bias, using a completely, antibody-independent new method based on “click chemistry”. This ground-breaking method will ensure that you capture the most cells types, including those that are prone to degradation, without limitation on the species.
Phone (Germany)：+49 221 16824777
Phone (APAC)：+65 6990 5987
Copyright © 2023 Singleron Biotechnologies